The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

CA378386067

Gene: SHOC2
Condition: RASopathy
Inheritance Mode: Autosomal dominant inheritance
UUID: cfe4649b-118d-4271-88f3-f0ef6ea17208

HGVS expressions

NR_136749.1:n.116-20704A>T
NC_000010.11:g.110964924A>T
CM000672.2:g.110964924A>T
NC_000010.10:g.112724682A>T
CM000672.1:g.112724682A>T
NC_000010.9:g.112714672A>T
NG_028922.1:g.50382A>T
NM_001269039.1:c.566A>T
NM_007373.3:c.566A>T
NM_001269039.2:c.566A>T
NM_001324336.1:c.566A>T
NM_001324337.1:c.566A>T
ENST00000265277.9:c.566A>T
ENST00000369452.8:c.566A>T
ENST00000451838.1:n.74A>T
ENST00000489390.1:n.56-35491A>T

Uncertain Significance

Met criteria codes 3
PS4_Supporting PP2 PM2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
RASopathy VCEP
The c.556A>T (p.Tyr189Phe) variant in the SHOC2 gene is absent from large population studies (PM2; gnomAD, http://gnomad.broadinstitute.org). The variant is located in the SHOC2 gene, which has been defined by the ClinGen RASopathy Expert Panel as a gene with a low rate of benign missense variants and pathogenic missense variants are common (PP2; PMID: 29493581). In summary, the clinical significance of the p.Tyr189Phe variant is uncertain. RASopathy-specific ACMG/AMP criteria applied (PMID:29493581): PM2, PP2.
Met criteria codes
PS4_Supporting
3 year old male with speech delays, relative macrocephaly, hydronephrosis, and borderline short stature. He did not have classic facial gestalt of Noonan syndrome. He had a normal echocardiogram. Variant was also detected in the proband's mother who presented with short stature and mild hypertelorism. She had a normal echocardiogram. She had an unusual facial gestalt. No family history of loose anagen hair. Proband's hair wasn't easily pluckable. Neither individuals had a history of seizures.
PP2
The variant is located in the SHOC2 gene, which has been defined by the ClinGen RASopathy Expert Panel as a gene with a low rate of benign missense variants and pathogenic missense variants are common (PP2; PMID: 29493581).
PM2
Variant is absent from gnomAD
Approved on: 2019-09-16
Published on: 2019-12-03
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.